BCL2 and neoplasm: OME treatment leads to significantly increased antioxidant enzyme activity, reduced MDA contents, up-regulation of Bax, and down-regulation of Bcl-2 protein expressions (facilitating tumor cell apoptosis), which could be correlated with its phytoconstituents, including phenolic, flavonoid, alkaloid, and naphthoquinones.